Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Suitable Bone Markers Assessing Bone Status in Patients With Both Coronary Artery Disease and Diabetes Publisher



Maghbooli Z1 ; Emamgholipour S2 ; Hosseinnezhad A3, 6 ; Shirzad M4 ; Gorgani Firuzjaee S5
Authors
Show Affiliations
Authors Affiliations
  1. 1. Tehran University of Medical Sciences, Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran, Iran
  2. 2. Tehran University of Medical Sciences, Clinical Biochemistry Department, Faculty of Medicine, Tehran, Iran
  3. 3. Tehran University of Medical Sciences, Osteoporosis Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran, Iran
  4. 4. Heart Center, Tehran University of Medical Sciences, Tehran, Iran
  5. 5. AJA University of Medical Sciences, Department of Medical Laboratory Sciences, School of Allied Health Medicine, Tehran, Iran
  6. 6. Shariati Hospital, EMRI, 5th floor, North Karegar Avenue, P.O Box: 1411413137, Tehran, Iran

Source: Journal of Diabetes and Metabolic Disorders Published:2016


Abstract

Background: We aimed to investigate the bone turnover markers in coronary artery disease (CAD) patients with and without type 2 diabetes (T2DM) in comparison with control subjects without CAD and T2DM. Methods: This cross-sectional study was performed on 45 subjects undergoing elective heart surgery; either for coronary artery bypass grafting or for valve surgery. According to angiographic results, participants were grouped in two groups with CAD (n=33) and without CAD (n=12). The serum levels of osteocalcin (OC), procollagen I aminoterminal propeptide (P1NP) and carboxy-terminal collagen crosslinks (CTX), as bone turnover markers, as well as serum levels of 25 (OH) vitamin D3, PTH, and common metabolic factors were analyzed in all participants. Results: Serum levels of bone markers did not differ in patients with CAD compared to non-CAD subjects. Regarding metabolic factors, serum levels of FBG had invert correlation with OC in CAD patients (p=0.004). The data of subgroup analysis showed serum levels of OC and CTX were statistically significant lower in CAD-DM than CAD-non DM (p<0.05). There were not any significant differences in the P1NP levels between groups. Conclusions: Our data suggest that CTX and OC would be used as suitable bone markers in CAD patients with T2DM. However, further clinical studies need to establish the role of these markers in CAD patients with diabetes. © 2016 The Author(s).
Related Docs
1. The Association Between Osteocalcin and C-Reactive Protein; a Relation of Bone With Inflammation: A Systematic Review and Meta-Analysis, Hormone and Metabolic Research (2019)
2. Mechanisms Involved in Altered Bone Metabolism in Diabetes: A Narrative Review, Journal of Diabetes and Metabolic Disorders (2016)
3. The Inverse Association of Body Adiposity Index and Bone Health in the Older Adults: A Report From a Developing Country, International Journal of Clinical Practice (2021)
4. The Association of Coronary Artery Calcium Score and Osteoporosis in Postmenopausal Women: A Cross-Sectional Study, Journal of Bone Metabolism (2022)
5. Association Between Serum Osteocalcin and Body Mass Index: A Systematic Review and Meta-Analysis, Endocrine (2017)
Experts (# of related papers)
View all Related Experts
Sakineh Shab-Bidar (2)
Noushin Fahimfar (1)